VYOME HOLDINGS, INC. Impairment of Long-Lived Assets Held-for-use
VYOME HOLDINGS, INC. (HIND) reported Impairment of Long-Lived Assets Held-for-use of $36.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2025-04-04
- VYOME HOLDINGS, INC. impairment of long-lived assets held-for-use for the quarter ending 2021-03-31 was $0.00.
- VYOME HOLDINGS, INC. impairment of long-lived assets held-for-use for the quarter ending 2020-12-31 was -$57.00K.
- VYOME HOLDINGS, INC. impairment of long-lived assets held-for-use for the quarter ending 2020-09-30 was $1.20M.
- VYOME HOLDINGS, INC. impairment of long-lived assets held-for-use for the quarter ending 2020-06-30 was $1.20M.
- VYOME HOLDINGS, INC. impairment of long-lived assets held-for-use for fiscal 2024 was $36.00K, a 95.37% decline from fiscal 2023.
- VYOME HOLDINGS, INC. impairment of long-lived assets held-for-use for fiscal 2023 was $777.00K.
- VYOME HOLDINGS, INC. impairment of long-lived assets held-for-use for fiscal 2020 was $1.20M.
- VYOME HOLDINGS, INC. impairment of long-lived assets held-for-use for fiscal 2017 was $0.00.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 12 month | Impairment of Long-Lived Assets Held-for-use 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $36.00K 10-K · filed 2025-04-04 | ||||
| 2023-12-31 | $777.00K 10-K · filed 2025-04-04 | $500.00K 10-K · filed 2024-04-01 | |||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-12 | -$57.00K derived: sum of 2 quarters · filed 2021-05-12 | $1.14M derived: sum of 3 quarters · filed 2021-05-12 | $2.34M derived: sum of 4 quarters · filed 2021-05-12 | |
| 2020-12-31 | -$57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $1.14M derived: sum of 2 quarters · filed 2021-03-12 | $2.34M derived: sum of 3 quarters · filed 2021-03-12 | $1.20M 10-K · filed 2021-03-12 | |
| 2020-09-30 | $1.20M 10-Q · filed 2020-11-06 | $2.40M derived: sum of 2 quarters · filed 2020-11-06 | $1.26M 10-Q · filed 2020-11-06 | ||
| 2020-06-30 | $1.20M 10-Q · filed 2020-07-30 | $1.26M 10-Q · filed 2020-07-30 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-12 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 10-Q · filed 2020-11-06 | |||
| 2019-06-30 | $0.00 10-Q · filed 2020-07-30 | ||||
| 2017-12-31 | $0.00 10-K · filed 2018-03-05 | ||||
| 2016-12-31 | $0.00 10-K · filed 2018-03-05 | ||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |